The Recombinant Human EGF Market is estimated to be valued at US$ 9.3 billion in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period of 2023 to 2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Recombinant Human EGF Market refers to the market for recombinant human epidermal growth factors (EGF), which are used in various...
0 Commentarios
0 Acciones
1240 Views
0 Vista previa